Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-14-013436
Filing Date
2014-08-29
Accepted
2014-08-29 18:04:17
Documents
1
Period of Report
2014-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 7878
  Complete submission text file 0001179110-14-013436.txt   9361
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 132 PURDURE AVENUE KENGSINGTON CA 94708
Business Address
BJERKHOLT ERIC (Reporting) CIK: 0001197350 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 141076125